TXA127 for the Treatment of Severe COVID-19

NCT04401423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: TXA127
DRUG: Placebo

Sponsor

Columbia University

Collaborators

[object Object]